Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hako-Med is a medical technology company specializing in the development and manufacturing of advanced electromedical devices, primarily focused on its proprietary Horizontal Therapy (HT). Horizontal Therapy is a unique form of bioelectric treatment that combines the effects of both stimulatory and non-stimulatory electrical currents to treat chronic and acute pain, as well as various musculoskeletal and neurological conditions. The company's flagship products are used by healthcare professionals globally to improve patient outcomes in physical therapy, rehabilitation, and pain management. Hako-Med's technology is designed to influence metabolic processes at the cellular level, promoting healing and reducing inflammation without the need for invasive procedures or pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hako-Med.